Company intelligence / Profile preview

Novosound

Motherwell, Scotland, United Kingdom

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Novosound has demonstrated and presented real-world clinical accuracy for its wearable, wireless ultrasound platform, with the first-ever continuous, cuffless blood pressure monitor in smartwatches and rings. The technology is undergoing active commercialization with clinical results presented at the IEEE International Ultrasonics Symposium and ongoing collaborations with leading medical institutions and commercial partners[1][3][5].

Therapeutic areas: CardiovascularOther
Modalities: Device
Industry: Physiological Monitoring

Partnerships

PAVmed Inc.Texas Medical CentreBaylor College of MedicineTech companies in digital wearables

Beyond the preview

Go deeper on Novosound.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novosound.

Explore the full profile